MPX Competitors

MPXOF Stock  USD 0.0001  0.00  0.00%   
The company classifies itself in the Drug Manufacturers—Specialty & Generic industry (Healthcare sector). MPX International Corp operates alongside Orphazyme A/S and other firms in the same space. Peer context helps frame relative positioning. This peer module benchmarks MPX International across key technical and fundamental signals.

MPX International and Orphazyme A/S Correlation Snapshot

Specify up to 10 symbols:
Investors who believe in mean reversion view MPX International's price extremes not as permanent states but as temporary dislocations that create opportunities for disciplined, contrarian capital allocation.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
A complete picture of MPX International's investment merit requires comparative analysis. How MPX International's growth rates, profitability, and capital efficiency stack up against peers is often the deciding factor in investment decisions.

MPX International Competition Correlation Matrix

Correlation analysis between MPX International Corp and its competitors helps investors understand whether diversification is real or only superficial inside the same peer group. This matrix is most informative when investors want to know whether adding another peer would improve diversification, increase crowding, or leave total risk largely unchanged.

High positive correlations

SPLMHCANF
AOLSHCANF
QBIOHCANF
AOLSSPLM
QBIOSPLM
QBIOAOLS
  

High negative correlations

LOWLFDZCA
SDCCQLOWLF
OZYMFQBIO
OZYMFSDCCQ
QBIOSDCCQ
OZYMFAOLS

Risk-Adjusted Indicators

There is a big difference between MPX Pink Sheet performing well and MPX International Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MPX International's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
USMJ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
HCANF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CNTTQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SPLM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DZCA 90.13 44.76  0.00 -3.22  0.00 
 0.00 
2,700
LOWLF 84.09 41.77 1.12 -8.60 19.82
70.48
1,900
AOLS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SDCCQ 26.90 11.97  0.00 -0.53  0.00 
 0.00 
990.00
QBIO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
OZYMF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

MPX International Competitive Analysis

Investors tracking MPX International should compare MPX International's financial results to its peer group to contextualize performance. A company that consistently outperforms MPX International's competitors on margin and growth metrics is typically a stronger long-term hold.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MPXOF HCANF SPLM DZCA LOWLF AOLS SDCCQ QBIO OZYMF
 0.00 
0.0001
MPX
 0.00 
0.0001
Halo
 0.00 
0.0001
Sentry
 364.29 
0.01
DrazCanna
 0.00 
0.0001
Lowell
 0.00 
0.0001
Aeolus
 90.00 
0.0001
SmileDirectClub
 0.00 
0.0001
QBIO
 0.00 
90.00
Orphazyme
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Number Of Shares Shorted
Current Liabilities
Total Asset
Debt To Equity
Target Price
Short Ratio
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

MPX International Peer Performance Charts

How to Analyze MPX International Against Peers

MPX International's peer analysis compares MPX International with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether MPX International trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where MPX International leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.